Immunosuppressive Therapy
Sponsors
City of Hope Medical Center, University of Nebraska, Hoffmann-La Roche, Fred Hutchinson Cancer Center, Peking Union Medical College Hospital
Conditions
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Nasal Type Extranodal NK/T-cell LymphomaBlastic Phase Chronic Myelogenous LeukemiaChronic Graft Versus Host DiseaseChronic Myeloproliferative DisordersContiguous Stage II Adult Burkitt Lymphoma
Phase 2
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
TerminatedNCT01044745
Start: 2009-12-10End: 2017-10-10Updated: 2023-09-06
Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease
CompletedNCT03483675
Start: 2018-06-06End: 2021-03-03Updated: 2021-06-23
Unknown Phase
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
TerminatedNCT00813501
Start: 2008-06-30End: 2010-06-30Updated: 2011-03-07
An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil
CompletedNCT01672957
Start: 2011-09-30End: 2015-07-31Updated: 2016-10-11
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
RecruitingNCT05860400
Start: 2023-05-17End: 2026-09-30Target: 39Updated: 2025-11-19
Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study
RecruitingNCT06845410
Start: 2025-04-01End: 2026-12-31Target: 120Updated: 2025-11-19
Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
Not yet recruitingNCT06981845
Start: 2025-06-01End: 2028-06-01Target: 52Updated: 2025-05-21